Matej Mikulic
Research expert covering health, pharma & medtech
AI in healthcare - statistics & facts
Artificial intelligence in healthcare has moved beyond experimentation into a phase of structured investment and scaled deployment. Building on earlier momentum around diagnostics and workflow automation, the market is now increasingly shaped by AI-first strategies, particularly following the rise of generative AI. Investment patterns reflect this shift: while overall digital health funding has normalized after pandemic peaks, AI-focused segments continue to attract a disproportionate share of capital, with market revenues projected to grow strongly over the coming years, reflecting sustained demand for AI-enabled healthcare solutions. At the same time, providers and payers are prioritizing use cases that deliver measurable efficiency gains—such as clinical documentation, triage support, and imaging analysis—indicating a transition from hype to ROI-driven adoption.
Adoption accelerates across care delivery
The increasing relevance of AI is mirrored in its growing adoption across healthcare systems and among medical professionals. Globally, nearly half of clinicians reported using AI for work-related purposes in 2025, with adoption rates particularly high in regions such as South America and Asia-Pacific. In the United States, adoption has expanded rapidly, with usage rates in some specialties exceeding 60 percent and overall prevalence rising sharply within just a few years. Younger physicians tend to adopt AI more readily, suggesting continued growth as digital-native cohorts enter the workforce. At the same time, general practitioners increasingly rely on generative AI for administrative and clinical support tasks, highlighting how AI is becoming embedded in everyday medical workflows rather than remaining a specialized tool.
AI expands across healthcare use cases
AI applications in healthcare are rapidly expanding, spanning administrative efficiency, clinical decision support, and patient engagement. Physicians are increasingly using AI for tasks such as documentation, care plan generation, and medical research summaries, with some use cases already adopted by a majority of practitioners or expected to be implemented in the near term. The rise of ambient AI tools, such as automated note-taking systems, further illustrates how AI is reducing administrative burdens and streamlining workflows. Beyond clinical settings, patient-facing applications are also gaining traction: a notable share of consumers report using AI chatbots for health information, with many taking follow-up actions such as consulting providers or changing health behaviors. This broadening of use cases underscores AI’s transition from isolated innovation to a pervasive layer across healthcare delivery.
Strategic outlook
Artificial intelligence in healthcare is transitioning from broad experimentation to more targeted, value-driven deployment. Industry analyses show providers prioritizing applications that address operational constraints—especially administrative burden and workforce shortages—over complex clinical use cases. This aligns with rising uptake of tools such as documentation assistants and workflow automation, which deliver clearer short-term returns than autonomous diagnostics.
At the same time, scaling remains tied to data infrastructure and governance. Markets with more centralized health data ecosystems, such as China, are better positioned to accelerate implementation. However, concerns around data privacy, transparency, and clinical validation continue to shape adoption. As regulatory frameworks mature, AI will expand further into clinical decision-making, though unevenly, balancing innovation with trust and accountability.
